» Articles » PMID: 25249623

A Real-time Fluorescence Polarization Activity Assay to Screen for Inhibitors of Bacterial Ribonuclease P

Overview
Specialty Biochemistry
Date 2014 Sep 25
PMID 25249623
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Ribonuclease P (RNase P) is an essential endonuclease that catalyzes the 5' end maturation of precursor tRNA (pre-tRNA). Bacterial RNase P is an attractive potential antibacterial target because it is essential for cell survival and has a distinct subunit composition compared to the eukaryal counterparts. To accelerate both structure-function studies and discovery of inhibitors of RNase P, we developed the first real-time RNase P activity assay using fluorescence polarization/anisotropy (FP/FA) with a 5' end fluorescein-labeled pre-tRNAAsp substrate. This FP/FA assay also detects binding of small molecules to pre-tRNA. Neomycin B and kanamycin B bind to pre-tRNAAsp with a Kd value that is comparable to their IC50 value for inhibition of RNase P, suggesting that binding of these antibiotics to the pre-tRNA substrate contributes to the inhibitory activity. This assay was optimized for high-throughput screening (HTS) to identify specific inhibitors of RNase P from a 2880 compound library. A natural product derivative, iriginol hexaacetate, was identified as a new inhibitor of Bacillus subtilis RNase P. The FP/FA methodology and inhibitors reported here will further our understanding of RNase P molecular recognition and facilitate discovery of antibacterial compounds that target RNase P.

Citing Articles

Studying Exoribonuclease Activity Using Fluorescence Anisotropy Assay.

Kus K, Vasiljeva L Methods Mol Biol. 2024; 2863:71-80.

PMID: 39535705 DOI: 10.1007/978-1-0716-4176-7_6.


Targeting Ribonucleases with Small Molecules and Bifunctional Molecules.

Borgelt L, Wu P ACS Chem Biol. 2023; 18(10):2101-2113.

PMID: 37382390 PMC: 10594538. DOI: 10.1021/acschembio.3c00191.


Overview on Strategies and Assays for Antibiotic Discovery.

Rutten A, Kirchner T, Musiol-Kroll E Pharmaceuticals (Basel). 2022; 15(10).

PMID: 36297414 PMC: 9607151. DOI: 10.3390/ph15101302.


Identification of potent inhibitors of arenavirus and SARS-CoV-2 exoribonucleases by fluorescence polarization assay.

Hernandez S, Feracci M, De Jesus C, El Kazzi P, Kaci R, Garlatti L Antiviral Res. 2022; 204:105364.

PMID: 35716929 PMC: 9212739. DOI: 10.1016/j.antiviral.2022.105364.


RNase P Inhibitors Identified as Aggregators.

Schencking I, Schafer E, Scanlan J, Wenzel B, Emmerich R, Steinmetzer T Antimicrob Agents Chemother. 2021; 65(8):e0030021.

PMID: 33972249 PMC: 8284443. DOI: 10.1128/AAC.00300-21.


References
1.
Mikkelsen N, Brannvall M, Virtanen A, Kirsebom L . Inhibition of RNase P RNA cleavage by aminoglycosides. Proc Natl Acad Sci U S A. 1999; 96(11):6155-60. PMC: 26851. DOI: 10.1073/pnas.96.11.6155. View

2.
Vioque A . Protein synthesis inhibitors and catalytic RNA. Effect of puromycin on tRNA precursor processing by the RNA component of Escherichia coli RNase P. FEBS Lett. 1989; 246(1-2):137-9. DOI: 10.1016/0014-5793(89)80269-8. View

3.
Komine Y, Kitabatake M, Yokogawa T, Nishikawa K, Inokuchi H . A tRNA-like structure is present in 10Sa RNA, a small stable RNA from Escherichia coli. Proc Natl Acad Sci U S A. 1994; 91(20):9223-7. PMC: 44784. DOI: 10.1073/pnas.91.20.9223. View

4.
Gobert A, Gutmann B, Taschner A, Gossringer M, Holzmann J, Hartmann R . A single Arabidopsis organellar protein has RNase P activity. Nat Struct Mol Biol. 2010; 17(6):740-4. DOI: 10.1038/nsmb.1812. View

5.
Seif E, Altman S . RNase P cleaves the adenine riboswitch and stabilizes pbuE mRNA in Bacillus subtilis. RNA. 2008; 14(6):1237-43. PMC: 2390808. DOI: 10.1261/rna.833408. View